Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ainsley Ross"'
Autor:
Joseph P. McGuirk, Constantine S. Tam, Nicolaus Kröger, Peter A. Riedell, Hemant S. Murthy, Phoebe Joy Ho, Joseph E. Maakaron, Edmund K. Waller, Farrukh T. Awan, Paul J. Shaughnessy, Armin Ghobadi, Michael R. Bishop, Ana Alfonso-Pierola, Michael Dickinson, Praveen Ramakrishnan Geethakumari, Ainsley Ross, William Stevens, Huansheng Xu, Anna Ma, Sarah Beaussant Cohen, Richard T. Maziarz, Carlos Bachier
Publikováno v:
Blood. 140:10303-10306
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7203b7ac90153d8c9b7e2ef9401cd21
https://doi.org/10.1182/blood-2022-166432
https://doi.org/10.1182/blood-2022-166432
Autor:
Patrick Y. Wen, Andrew D. Norden, Ainsley Ross, Mary Gerard, Alona Muzikansky, M. Brenna McNamara, Jan Drappatz, Phuong Phan, Santosh Kesari, Karly David
Publikováno v:
Journal of Neuro-Oncology. 92:149-155
Recent clinical trial results suggest that anti-angiogenic therapy may be effective against recurrent malignant glioma. Though these treatments prolong progression-free survival, the extent to which they prolong overall survival is unknown. We pooled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720678a1a6c92bc81e64134222ad4ff8
https://doi.org/10.1007/s11060-008-9745-8
https://doi.org/10.1007/s11060-008-9745-8
Autor:
John M. Goldberg, Nicholas S. Wilson, Jeffrey Raizer, Olga Shebanova, Priya Kumthekar, R.B. Stein, Robert Wesolowski, Ainsley Ross, Jimmy J. Hwang, Carleen Gentry, Elise Drouin, Jean-Marie Cuillerot, Breelyn A. Wilky, Jennifer Buell
Publikováno v:
Journal of Clinical Oncology. 35:3075-3075
3075 Background: AGEN1884 is a fully human IgG1 monoclonal antibody targeting the co-inhibitory protein cytotoxic T lymphocyte-associated protein 4 (CTLA-4). CTLA-4 blockade has been shown to augment T cell activation and proliferation, resulting in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0db0395dad7f93651ad11fb72dc3c439
https://doi.org/10.1200/jco.2017.35.15_suppl.3075
https://doi.org/10.1200/jco.2017.35.15_suppl.3075
Autor:
Jeffrey R. Keefer, Onyinye Onyekwere, Maureen Okam, Joshua J. Field, Federico Campigotto, David G. Nathan, Elaine M. Majerus, Ainsley Ross, Joel Linden, Gene Lin, Donna Neuberg
Publikováno v:
Blood. 121(17)
Adenosine A2A receptor (A2AR) agonists reduce invariant natural killer T (iNKT) cell activation and decrease inflammation in sickle cell disease (SCD) mice. We conducted a phase 1 trial of the A2AR agonist regadenoson in adults with SCD. The target d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c87280eac0645447c1ac0817af128fbf
https://pubmed.ncbi.nlm.nih.gov/23377438
https://pubmed.ncbi.nlm.nih.gov/23377438
Autor:
David G, Nathan, Joshua, Field, Gene, Lin, Donna, Neuberg, Elaine, Majerus, Onyinye, Onyekwere, Jeffrey, Keefer, Maureen, Okam, Ainsley, Ross, Joel, Linden
Publikováno v:
Transactions of the American Clinical and Climatological Association. 123
A humanized murine sickle cell–disease (SCD) model (NY1DD) has been used to study ischemia/reperfusion injury (IRI) in sickle cell anemia, and iNKT cells (a very small subset of murine and human T cells) have been found to instigate such injury in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::99959111451f93160b091ed552fea446
https://pubmed.ncbi.nlm.nih.gov/23303999
https://pubmed.ncbi.nlm.nih.gov/23303999
Autor:
Ainsley Ross, Gregory A. Abel, Maureen Okam, Rachel Wentz, Elyse Mandell, Nathanael D. Hevelone
Publikováno v:
American Journal of Hematology. 87:E123-E124
Oral iron replacement is the standard therapy in iron-deficiency anemia (IDA). However, 59% of patients have gastrointestinal toxicity. With impaired iron uptake from the gastrointestinal tract (in anemia of chronic disease (ACD) or after bariatric s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c60abf851cfd53438d9ca2cd819ceb4c
https://doi.org/10.1002/ajh.23322
https://doi.org/10.1002/ajh.23322
Autor:
Joshua J. Field, Joel Linden, Donna Neuberg, Ainsley Ross, David G. Nathan, Federico Campigotto, Gene Lin, Elaine M. Majerus, Onyinye Onyekwere, Maureen Okam
Publikováno v:
Blood. 118:849-849
Abstract 849FN2 Adenosine 2A receptor (A2AR) agonists decrease pulmonary inflammation and injury in a murine model of sickle cell disease (SCD) by interrupting invariant NKT (iNKT) cell activation that occurs as a result of vaso-occlusion (Clin Immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5db415f1370a5551cd5d6ba2e16466e5
https://doi.org/10.1182/blood.v118.21.849.849
https://doi.org/10.1182/blood.v118.21.849.849
Publikováno v:
Journal of Neuro-Oncology; Apr2009, Vol. 92 Issue 2, p149-155, 7p